Editorial Note: Originally published on July 1, 2026, this brief was updated on August 12, 2026, to incorporate the fiscal implications of the recent CMS star rating recalculations and their subsequent impact on 2027 Medicare Advantage quality bonus spending.
The Medicare Advantage (MA) quality bonus program, a cornerstone of the Affordable Care Act (ACA) designed to incentivize high-quality care, has evolved into a significant driver of federal healthcare spending. While intended to reward excellence and guide consumer choice, the program faces mounting scrutiny from policymakers and independent watchdogs who question its efficacy, equity, and fiscal sustainability. As of 2026, the program serves as a multi-billion-dollar apparatus that increasingly shapes the financial landscape of private Medicare plans.
Main Facts: The Anatomy of a Multi-Billion Dollar Program
At its core, the quality bonus program provides increased federal payments to Medicare Advantage plans that achieve a star rating of 4 or higher on a five-star scale. These bonus payments—which are not distributed as direct cash but rather as higher benchmarks that permit increased plan rebates—are designed to subsidize supplemental benefits. These include dental, vision, and hearing coverage, as well as reduced cost-sharing and lower Part B premiums.
However, the mechanism is complex. The star ratings, intended to simplify consumer decision-making, are reported at the contract level rather than the plan level. This creates a "blended" quality score that may mask significant disparities in performance across the various plans bundled within a single contract. Critics, including the Medicare Payment Advisory Commission (MedPAC), have long argued that these ratings incorporate an overwhelming array of measures, fail to adequately account for social risk factors, and ultimately serve as a blunt instrument for measuring true clinical quality.
Chronology: From ACA Incentive to Fiscal Challenge
The evolution of the bonus program tracks alongside the meteoric rise of the Medicare Advantage market.
- 2015: The program began gaining traction, with total federal spending on quality bonuses reaching $3.0 billion.
- 2018: The Congressional Budget Office (CBO) projected that eliminating the program would save the federal government nearly $100 billion over a decade. Since then, enrollment in MA has surged beyond CBO’s initial projections, suggesting that the potential savings today would be significantly higher.
- 2025–2026: Enrollment reached 35 million, nearly 5 million more than once anticipated. Spending on quality bonuses climbed to $12.7 billion in 2025 and rose to $13.4 billion in 2026.
- 2026–2027: Recent legal challenges regarding star rating methodologies, most notably by Clover Health, have forced CMS to recalculate ratings, resulting in an estimated $600 million in additional bonus spending projected for 2027 alone.
Supporting Data: The Fiscal Trajectory
The financial footprint of the bonus program is stark. In 2026, the program accounted for 2.3% of the projected $574 billion in total Medicare Advantage payments. This spending has more than quadrupled since 2015.
Enrollment and Spending Disparities
Currently, 68% of all Medicare Advantage enrollees—approximately 24 million people—are in plans that qualify for bonus payments. However, the distribution of these funds is not uniform:
- Employer- and Union-Sponsored Plans: These plans represent 16% of total MA enrollment but command 20% ($2.6 billion) of bonus spending. The average payment increase per person in these group plans is $466, significantly higher than the $381 for individual plans or $318 for Special Needs Plans (SNPs).
- Parent Organization Variance: The benefits are highly concentrated. UnitedHealth Group, which holds 26% of the market, is projected to receive $3.9 billion in bonus-related spending in 2026. Conversely, organizations like Humana have seen their bonus potential fluctuate wildly due to volatile star ratings, highlighting the instability of the current quality metrics.
The "Underestimate" Factor
It is important to note that the $13.4 billion figure for 2026 is a "lower-bound" estimate. This calculation assumes an average health risk score of 1.0 for all enrollees. When accounting for "coding intensity"—the practice of capturing more comprehensive diagnostic data to increase risk scores—MedPAC estimates that the actual impact on benchmarks could be as high as $16 billion. When factoring in the broader influence of coding intensity and favorable selection, these systemic issues add approximately $76 billion in total annual spending to the Medicare program.
Official Responses and Regulatory Shifts
The Centers for Medicare & Medicaid Services (CMS) has acknowledged the need for reform. In 2026, the agency finalized changes to the star rating system, slated to take effect for the 2029 ratings based on 2027 performance. These changes involve stripping out administrative measures that no longer effectively differentiate plan quality.
While intended to streamline the process, the irony of this "simplification" is that it is projected to increase Medicare spending by $18.6 billion over the next decade. By removing lower-performing administrative metrics, more plans are expected to qualify for the 4-star threshold, thereby triggering the bonus payment mechanism.
Industry stakeholders remain divided. Insurers, facing pressure from shareholders and the need to maintain competitive benefit packages, argue that the star ratings are a vital lifeline for supplemental benefits. Meanwhile, groups like the Paragon Institute and the Center for American Progress have published varying proposals, ranging from complete elimination of the bonus program to fundamental structural reforms.
Implications: The Path Forward
The reliance on quality bonuses to fund supplemental benefits has created a "benefit trap." Millions of seniors have become accustomed to dental, vision, and hearing coverage—benefits not provided by traditional Medicare—that are explicitly tied to these bonus payments. Any move to scale back or eliminate the program could lead to a reduction in these popular benefits, creating significant political blowback.
1. The Transparency Gap
The lack of data regarding employer- and union-sponsored plans remains a major hurdle for policymakers. Because these plans often receive higher bonus payments per enrollee, there is a legitimate question as to whether the federal government is subsidizing benefits that these employers would have provided regardless. Without better transparency, Congress is essentially flying blind on a significant portion of the Medicare budget.
2. The Legal Tug-of-War
The recent wave of litigation, where insurers have successfully challenged CMS star ratings in court, suggests that the current methodology is legally precarious. Every time a court forces a recalculation, federal spending increases. If CMS continues to lose these battles, the "bonus" portion of the Medicare budget could become even more difficult to control.
3. Sustainability in an Aging Society
With Medicare facing long-term fiscal pressures, the growth of the bonus program is becoming increasingly difficult to justify as a "quality" incentive. When the program grows faster than enrollment and fails to account for the social risk factors of the most vulnerable populations (such as those in Special Needs Plans), it risks becoming a permanent subsidy for insurers rather than a dynamic reward for clinical excellence.
In conclusion, the Medicare Advantage quality bonus program stands at a crossroads. While it has undeniably expanded the scope of supplemental benefits for millions of seniors, it has also become a source of fiscal instability and regulatory friction. As policymakers look toward the next decade, the challenge will be to decouple the desire for high-quality care from a payment structure that may be prioritizing administrative maneuvering over meaningful health outcomes. Whether the program is reformed, replaced, or ended, the coming years will likely be defined by a shift toward more rigorous, evidence-based quality metrics and a tighter leash on federal spending.
About the Author
